What's the latest with the Trump admin's promise on lower drug prices in Medicaid?

NPR | By Sydney Lupkin,

Scott Detrow

Published September 14, 2026 at 2:34 PM MDT

The Trump admin's drug price deals came with a promise to offer lower prices in Medicaid. But the goalposts keep moving. Instead of all drugs, it's just one or two. And the deadlines for states to voluntarily sign on has been pushed back twice. So what's the status?

Tags

All Things Considered

Sydney Lupkin

Sydney Lupkin is the pharmaceuticals correspondent for NPR, where she has reported on accelerated drug approvals whose confirmatory trials were overdue, Operation Warp Speed contract accountability, and the ripple effects of obesity drug shortages.

See stories by Sydney Lupkin

Scott Detrow

Scott Detrow is a host of All Things Considered, as well as NPR’s daily news podcast Consider This.

See stories by Scott Detrow

The Latest From Boise State Public Radio

Sheep Stories

The second season of Sheep Stories takes you deep into the archives to uncover the stories behind Idaho’s enduring sheep-ranching tradition. Listen, learn, and follow the trail into the stories that continue to shape sheep ranching in Idaho.

Listen Here

You make stories like this possible.

The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.

Your donation today helps make our local reporting free for our entire community.

Donate